According to market analysis, the Anti Microbial Anti Fungal Test Market size is expected to reach US$ 5.07 billion by 2031, registering a CAGR of 7.0% during 2025–2031. The increasing need for accurate microbial and fungal infection detection is driving adoption across hospitals, diagnostic laboratories, and research institutions. The global Anti Microbial/Anti Fungal Test Market Size is...

The Cancer remains one of the leading causes of mortality worldwide, driving pharmaceutical companies and healthcare providers to focus on the development of highly effective anti-cancer drugs. Technological advancements in drug discovery, increased adoption of precision medicine, and favorable regulatory support are accelerating the commercialization of next-generation oncology therapies....

The anti-infective drugs industry continues to play a crucial role in global healthcare systems. The rise in viral outbreaks, hospital-acquired infections, and chronic infectious conditions has strengthened the demand for effective therapies worldwide. Pharmaceutical companies are increasingly focusing on developing targeted therapies and combination drugs to address evolving microbial...